Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-01-27 @ 7:41 AM
Study NCT ID:
NCT02226861
Status:
COMPLETED
Last Update Posted:
2018-07-05
First Post:
2014-08-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-08-26
Start Date Type:
None
Primary Completion Date:
2018-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-06-27
Completion Date Type:
ACTUAL
First Submit Date:
2014-08-26
First Submit QC Date:
None
Study First Post Date:
2014-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-03
Last Update Post Date:
2018-07-05
Last Update Post Date Type:
ACTUAL